People's Health Press
ISSN 2096-2738 CN 11-9370/R
  • Official WeChat

  • Official Weibo

  • Official headlines

Electronic Journal of Emerging Infectious Diseases ›› 2020, Vol. 5 ›› Issue (4): 274-276.doi: 10.19871/j.cnki.xfcrbzz.2020.04.013

• Review • Previous Articles     Next Articles

Advances in clinical application research of mycobacterium vaccae on treatment of tuberculosis

Liu Chunling1, Yan Xiaofeng2   

  1. 1. Department of Pharmacy,Chongqing Public Health Medical Center,Chongqing 400036,China;
    2. Department of Tuberculosis,Chongqing Public Health Medical Center,Chongqing 400036,China
  • Received:2020-10-16 Online:2020-11-30 Published:2020-12-31

Abstract: As an adjunct to chemotherapy,Mycobacterium vaccae is helpful for patients with initial treatment of tuberculosis,recurrent treated tuberculosis,multi-drμg resistant tuberculosis,tuberculous pleurisy and TB preventive treatment in terms of improving cell-medicated immunity.This article aims to briefly describe the clinical application and research progress of Mycobacterium vaccae in the adjuvant treatment of tuberculosis in recent years.

Key words: Mycobacterium vaccae, Clinical application, Immunotherapy, Tuberculosis